Martin Bentler

Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy

David A. Williams, A. Schambach, G. Veres, 2020, Molecular therapy. Methods & clinical development.

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives

H. Büning, U. Hacker, M. Bentler, 2020, Cancers.

Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells

G. Song, A. Balakrishnan, Q. Yuan, 2019, Gut.

Role of miR‐203 in estrogen receptor‐mediated signaling in the rat uterus and endometrial carcinoma

S. Chittur, M. Tenniswood, M. Bentler, 2018, Journal of cellular biochemistry.

Modifying immune responses to adeno-associated virus vectors by capsid engineering

H. Büning, U. Hacker, Clara T. Schoeder, 2023, Molecular therapy. Methods & clinical development.

Growth differentiation factor 11 mitigates liver fibrosis via expansion of liver progenitor cells

G. Song, A. Balakrishnan, Z. Dai, 2020, Zeitschrift für Gastroenterologie.

DROSHA Knockout Leads to Enhancement of Viral Titers for Vectors Encoding miRNA-Adapted shRNAs

David A. Williams, R. Gregory, Robinson Triboulet, 2018, Molecular therapy. Nucleic acids.

Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies.

Martin Bentler, Hildegard Büning, Angela E Araujo, 2024, Human gene therapy.